Related references
Note: Only part of the references are listed.Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media
Min-Hyun Park et al.
AURIS NASUS LARYNX (2017)
Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center
Keila de Cassia Ferreira de Almeida Silva et al.
BURNS (2017)
Virulence and resistance features of Pseudomonas aeruginosa strains isolated from chronic leg ulcers
Mihaela Georgescu et al.
BMC INFECTIOUS DISEASES (2016)
Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis
Chengyi Ding et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Access to effective antimicrobials: a worldwide challenge
Ramanan Laxminarayan et al.
LANCET (2016)
Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India
Debarati Choudhury et al.
PLOS ONE (2016)
Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype
Melissa Agnello et al.
FRONTIERS IN MICROBIOLOGY (2016)
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
M. Berrazeg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
Genotypic analysis of Pseudomonas aeruginosa isolated from ocular infection
Satoshi Yamaguchi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones
Durga S. Borkar et al.
BMC OPHTHALMOLOGY (2014)
Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa
Hye Hyun Cho et al.
ANNALS OF LABORATORY MEDICINE (2014)
Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review
Teiji Sawa et al.
CRITICAL CARE (2014)
Quantitative Contributions of Target Alteration and Decreased Drug Accumulation to Pseudomonas aeruginosa Fluoroquinolone Resistance
Sebastian Bruchmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Anton Bankevich et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa
Melissa Agnello et al.
PLOS ONE (2012)
Detection of Type III Secretion System Virulence and Mutations in gyrA and parC Genes Among Quinolone-Resistant Strains of Pseudomonas aeruginosa Isolated from Imported Shrimp
Quynh T. Tran et al.
FOODBORNE PATHOGENS AND DISEASE (2011)
Genetic Characterization Indicates that a Specific Subpopulation of Pseudomonas aeruginosa Is Associated with Keratitis Infections
Rosalind M. K. Stewart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
PREVALENCE OF VIRULENCE GENES AMONG BULGARIAN NOSOCOMIAL AND CYSTIC FIBROSIS ISOLATES OF PSEUDOMONAS AERUGINOSA
Ivan Mitov et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2010)
Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa
R. S. Bradbury et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Alan R. Hauser
NATURE REVIEWS MICROBIOLOGY (2009)
Referral pathways and management of contact lens-related microbial keratitis in Australia and New Zealand
Lisa Keay et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa
A. Wong-Beringer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Risk factors and causative organisms in microbial keratitis
Matthew Green et al.
CORNEA (2008)
Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients with Pseudomonas aeruginosa Bacteremia
K. W. Garey et al.
JOURNAL OF CHEMOTHERAPY (2008)
Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis
Man H. Choy et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa
V. H. Tam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis
Pholawat Tingpej et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Acquisition and Evolution of the exoU locus in Pseudomonas aeruginosa
Bridget R. Kulasekara et al.
JOURNAL OF BACTERIOLOGY (2006)
Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR
JL Dumas et al.
FEMS MICROBIOLOGY LETTERS (2006)
Efflux-mediated antimicrobial resistance
K Poole
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Alterations in the GyrA and GyrB Subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa
JK Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Fluoroquinolone-resistant Pseudomonas aeruginosa:: risk factors for acquisition and impact on outcomes
DI Hsu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates:: Evidence for a possible association between O serotypes and exo genes
P Berthelot et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa
MC Wolfgang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU
H Sato et al.
EMBO JOURNAL (2003)
Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone
D Hocquet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong
JM Ling et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A
K Hirose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The MexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa:: Characterization of mutations compromising activity
L Adewoye et al.
JOURNAL OF BACTERIOLOGY (2002)
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
AR Hauser et al.
CRITICAL CARE MEDICINE (2002)
Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999:: Role of target enzyme in mechanism of fluoroquinolone resistance
T Akasaka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover et al.
NATURE (2000)
Share Paper
